Stallergenes Greer plc (STAGR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- GDPH2508812D
- Pages: 42
- September 2018
- Total Views:1122
- Region : Europe
- GlobalData
- Equity Research Report
Details
Summary
Stallergenes Greer plc (Stallergenes Greer), formerly Ares Allergy Holdings plc is a biopharmaceutical company, which provides treatments for allergy-related respiratory diseases. The company develops diagnostic tests and products with principal focus on allergies. The company offers treatment for important respiratory diseases, which include severe rhino conjunctivitis and rhinitis, and allergic asthma. Stallergenes Greer provides allergen immunotherapy in various dosage forms including injectable or subcutaneous injections, liquid sublinguals and solid sublinguals. Its research and development activities involve development of candidate products, laboratory research, clinical development and regulatory activities. The company distributes its products to various countries in North America, Europe, Africa; Asia and in Australia. Stallergenes Greer is headquartered in London, the UK.
Stallergenes Greer plc (STAGR)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Stallergenes Greer plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Stallergenes Greer plc, Medical Devices Deals, 2012 to YTD 2018 9
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
Ares Life Sciences Completes Acquisition Of Albion Medical And Its Subsidiary Greer Labs 11
Partnerships 12
Stallergenes Greer Enters into Agreement with Stanford University 12
Stallergenes Enters Into Co-Development Agreement With ActoGeniX 13
Stallergenes Exercises Option for Co-Development Agreement with ActoGeniX 14
Stallergenes Enters Into Distribution Agreement With Greer Labs For Oralair 15
DBV Technologies Exercises Option for R&D Agreement with Stallergenes for Birch Allergy Treatment 16
DBV Technologies Enters Into Research Agreement With Stallergenes 17
Merger 18
Ares Allergy, Stallergenes and Greer Labs Merge 18
Acquisition 19
Stallergenes Greer Acquires Medic Savoure 19
Stallergenes Acquires Alergo Pharma, Allergen Immunotherapy Company 20
Stallergenes Acquires 2% Stake in DBV Technologies 21
Stallergenes Greer plc-Key Competitors 22
Stallergenes Greer plc-Key Employees 23
Stallergenes Greer plc-Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 26
Financial Announcements 26
Jun 30, 2018: Stallergenes Greer delivers double digit growth and solid business performance in the first half of 2018; announces senior leadership succession plan 26
Aug 31, 2017: Stallergenes Greer Reports Strong First Half 2017 Results and Narrows 2017 Financial Guidance 33
Mar 29, 2017: Stallergenes Greer announces its 2016 full year results 36
Corporate Communications 38
Jun 29, 2017: Stallergenes Greer Announces Matthias Vogt as Chief Financial Officer 38
Jan 31, 2017: Stallergenes Greer Announces Resignation Of Chief Financial Officer 39
Other Significant Developments 40
Jun 07, 2018: Stallergenes Greer Provides Business Update and Refines Its 2018 Financial Outlook 40
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42
List Of Figure
List of Figures
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Stallergenes Greer plc, Medical Devices Deals, 2012 to YTD 2018 9
List Of Table
List of Tables
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Stallergenes Greer plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Stallergenes Greer plc, Deals By Therapy Area, 2012 to YTD 2018 8
Stallergenes Greer plc, Medical Devices Deals, 2012 to YTD 2018 9
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Ares Life Sciences Completes Acquisition Of Albion Medical And Its Subsidiary Greer Labs 11
Stallergenes Greer Enters into Agreement with Stanford University 12
Stallergenes Enters Into Co-Development Agreement With ActoGeniX 13
Stallergenes Exercises Option for Co-Development Agreement with ActoGeniX 14
Stallergenes Enters Into Distribution Agreement With Greer Labs For Oralair 15
DBV Technologies Exercises Option for R&D Agreement with Stallergenes for Birch Allergy Treatment 16
DBV Technologies Enters Into Research Agreement With Stallergenes 17
Ares Allergy, Stallergenes and Greer Labs Merge 18
Stallergenes Greer Acquires Medic Savoure 19
Stallergenes Acquires Alergo Pharma, Allergen Immunotherapy Company 20
Stallergenes Acquires 2% Stake in DBV Technologies 21
Stallergenes Greer plc, Key Competitors 22
Stallergenes Greer plc, Key Employees 23
Stallergenes Greer plc, Subsidiaries 24
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
Stallergenes Greer plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Summary
Stallergenes Greer plc (Stallergenes Greer), formerly Ares Allergy Holdings plc is a biopharmaceutical company, which provides treatments for allergy-related respiratory diseases. The company develops diagnostic tests and products with principal focus on allergies. The company offers treatment for important respiratory diseases, which include severe rhino conjunctivitis and rhinitis, and allergic asthma. Stallergenes Greer provides allergen immunotherapy in various dosage forms including injectable or subcutaneous injections, liquid sublinguals and solid sublinguals. Its research and development activities involve development of candidate products, laboratory research, clinical development and regulatory activities. The company distributes its products to various countries in North America, Europe, Africa; Asia and in Australia. Stallergenes Greer is headquartered in London, the UK.
Stallergenes Greer plc (STAGR)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Stallergenes Greer plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Stallergenes Greer plc, Medical Devices Deals, 2012 to YTD 2018 9
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
Ares Life Sciences Completes Acquisition Of Albion Medical And Its Subsidiary Greer Labs 11
Partnerships 12
Stallergenes Greer Enters into Agreement with Stanford University 12
Stallergenes Enters Into Co-Development Agreement With ActoGeniX 13
Stallergenes Exercises Option for Co-Development Agreement with ActoGeniX 14
Stallergenes Enters Into Distribution Agreement With Greer Labs For Oralair 15
DBV Technologies Exercises Option for R&D Agreement with Stallergenes for Birch Allergy Treatment 16
DBV Technologies Enters Into Research Agreement With Stallergenes 17
Merger 18
Ares Allergy, Stallergenes and Greer Labs Merge 18
Acquisition 19
Stallergenes Greer Acquires Medic Savoure 19
Stallergenes Acquires Alergo Pharma, Allergen Immunotherapy Company 20
Stallergenes Acquires 2% Stake in DBV Technologies 21
Stallergenes Greer plc-Key Competitors 22
Stallergenes Greer plc-Key Employees 23
Stallergenes Greer plc-Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 26
Financial Announcements 26
Jun 30, 2018: Stallergenes Greer delivers double digit growth and solid business performance in the first half of 2018; announces senior leadership succession plan 26
Aug 31, 2017: Stallergenes Greer Reports Strong First Half 2017 Results and Narrows 2017 Financial Guidance 33
Mar 29, 2017: Stallergenes Greer announces its 2016 full year results 36
Corporate Communications 38
Jun 29, 2017: Stallergenes Greer Announces Matthias Vogt as Chief Financial Officer 38
Jan 31, 2017: Stallergenes Greer Announces Resignation Of Chief Financial Officer 39
Other Significant Developments 40
Jun 07, 2018: Stallergenes Greer Provides Business Update and Refines Its 2018 Financial Outlook 40
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42
List Of Figure
List of Figures
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Stallergenes Greer plc, Medical Devices Deals, 2012 to YTD 2018 9
List Of Table
List of Tables
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Stallergenes Greer plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Stallergenes Greer plc, Deals By Therapy Area, 2012 to YTD 2018 8
Stallergenes Greer plc, Medical Devices Deals, 2012 to YTD 2018 9
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Ares Life Sciences Completes Acquisition Of Albion Medical And Its Subsidiary Greer Labs 11
Stallergenes Greer Enters into Agreement with Stanford University 12
Stallergenes Enters Into Co-Development Agreement With ActoGeniX 13
Stallergenes Exercises Option for Co-Development Agreement with ActoGeniX 14
Stallergenes Enters Into Distribution Agreement With Greer Labs For Oralair 15
DBV Technologies Exercises Option for R&D Agreement with Stallergenes for Birch Allergy Treatment 16
DBV Technologies Enters Into Research Agreement With Stallergenes 17
Ares Allergy, Stallergenes and Greer Labs Merge 18
Stallergenes Greer Acquires Medic Savoure 19
Stallergenes Acquires Alergo Pharma, Allergen Immunotherapy Company 20
Stallergenes Acquires 2% Stake in DBV Technologies 21
Stallergenes Greer plc, Key Competitors 22
Stallergenes Greer plc, Key Employees 23
Stallergenes Greer plc, Subsidiaries 24
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
Stallergenes Greer plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
: +91 98100 26150 
Related Reports
Page Excel Document | 
July 2020
Page 5 | July 2020
Page 5 | July 2020
Page 5 | July 2020
Page 5 | July 2020